<DOC>
	<DOCNO>NCT00655226</DOCNO>
	<brief_summary>The purpose study determine whether cognitive behavioral therapy ( CBT ) effective prevention depression interferon ribavirin treatment hepatitis C infection .</brief_summary>
	<brief_title>Prevention Depression HIV/HCV Co-infected Substance Abuse Patients</brief_title>
	<detailed_description>The treatment active hepatitis C HCV mono-infected HCV/HIV co-infected patient long difficult course , involve combination therapy interferon ribavirin 6 12 month , therapy significant side effect . Up 40 % patient treat develop depression due medication , turn lead discontinuation therapy lose opportunity prevent end stage liver disease . In fact , presence depression prior interferon treatment often exclude patient receive interferon therapy , thereby deny potentially life-saving treatment . Non-pharmacological therapy cognitive behavioral therapy ( CBT ) demonstrate efficacy treat primary depression numerous study include patient go treatment chronic medical illness . CBT well-established treatment modality show several large randomize trial effective , case effective , antidepressant . CBT also show efficacy prevent development depression emotional disorder high-risk population . Offering CBT prior treatment interferon non-depressed patient unique method may reduce rate depression increase adherence treatment without expose patient risk additional medication .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>1 . &gt; 21 year 2 . Speak read English 5th grade level high . 3 . Eligible ready begin PegInterferon Ribavirin ( PEGIFN/RBV ) therapy HCV Mount Sinai 's Primary Care practice JMFC 4 . HIV infect patient need CD4 count &gt; 100 demonstrated compliance retroviral therapy 5 . Not majorly depress upon entry study . 6 . Signed informed consent participate CBT study 1 . Majorly depress ( base administration PHQ9 , score consider Major Depressive Disorder ) . 2 . Admit actively abuse illicit drug alcohol 3 . Medical contraindication standard course interferon/ribavirin therapy ( eg : severe anemia , uncontrolled congestive heart failure ) 4 . Less one year life expectancy 5 . Current participation CBT relate psychotherapy 6 . Participation psychotherapy begin less 6 month CBT session begin . 7 . Initiated antidepressant medication le 6 month CBT session begin 8 . Severe comorbid psychiatric disease include bipolar disorder , severe personality disorder , psychotic disorder 9 . Active suicidal ideation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Cognitive Behavior Therapy</keyword>
	<keyword>Interferon-alpha</keyword>
	<keyword>Communicable Diseases</keyword>
	<keyword>Liver Diseases</keyword>
	<keyword>Depression</keyword>
	<keyword>Hepatitis , Chronic</keyword>
	<keyword>Interferons</keyword>
	<keyword>Ribavirin</keyword>
	<keyword>Hepatitis , Viral , Human</keyword>
	<keyword>Infection</keyword>
	<keyword>Hepatitis</keyword>
	<keyword>Mood Disorders</keyword>
	<keyword>Peginterferon alfa-2a</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Interferon Alfa-2a</keyword>
	<keyword>Interferon Alfa-2b</keyword>
	<keyword>Depressive Disorder , Major</keyword>
	<keyword>Depressive Disorder</keyword>
</DOC>